A Case Report of Monozygotic Twins with Smith-Magenis Syndrome
Overview
Social Sciences
Affiliations
Monozygotic 3.5-year-old twin boys presented for developmental assessment with a history of global developmental delay, behavioral issues including self-harm, and severe receptive and expressive language delays. Chromosome testing confirmed for both a 17p11.2 interstitial microdeletion commonly seen in Smith-Magenis syndrome (SMS), which is characterized by developmental delay, cognitive impairment, and facial and behavioral phenotype. To our knowledge, this is the first description in the literature of monozygotic twins with SMS. Despite their zygosity, the twins had marked differences in presentation including cardiac and renal anomalies, language development, and behavioral phenotype. Both twins displayed disordered speech development, impairments in social interaction, and stereotyped behaviors consistent with autism spectrum disorder, common in the vast majority of cases of SMS. Examining the differences in behavioral and clinical phenotype in monozygotic twins may lead to a better understanding of the cause of the clinical variability seen in SMS, as well as the natural history of this syndrome.
Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder.
Poisson A, Nicolas A, Bousquet I, Raverot V, Gronfier C, Demily C Int J Mol Sci. 2019; 20(14).
PMID: 31330985 PMC: 6679101. DOI: 10.3390/ijms20143533.
Behavioral disturbance and treatment strategies in Smith-Magenis syndrome.
Poisson A, Nicolas A, Cochat P, Sanlaville D, Rigard C, de Leersnyder H Orphanet J Rare Dis. 2015; 10:111.
PMID: 26336863 PMC: 4559928. DOI: 10.1186/s13023-015-0330-x.
Analysis of the sensory profile in children with Smith-Magenis syndrome.
Hildenbrand H, Smith A Phys Occup Ther Pediatr. 2011; 32(1):48-65.
PMID: 21599572 PMC: 10193281. DOI: 10.3109/01942638.2011.572152.
Neurodevelopment of children under 3 years of age with Smith-Magenis syndrome.
Wolters P, Gropman A, Martin S, Smith M, Hildenbrand H, Brewer C Pediatr Neurol. 2009; 41(4):250-8.
PMID: 19748044 PMC: 2785222. DOI: 10.1016/j.pediatrneurol.2009.04.015.